Skip to content
10-Q

Quarterly Report

PANDION THERAPEUTICS, INC.

0001564590-20-042014

← back to feed
Filed
Aug 31, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 31, 2020 29.52M sh
Capex Q2 2020 · Jun 30, 2020 $1.23M
Capex Q2 2020 · Jun 30, 2019 $437K
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$14.09M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$11.62M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $105.73M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $15.97M
Cash And Equivalents Q2 2020 · Jun 30, 2019 $16.08M
Current Liabilities Q2 2020 · Jun 30, 2020 $16.75M
Current Liabilities Q2 2020 · Dec 31, 2019 $7.03M
Total Liabilities Q2 2020 · Jun 30, 2020 $23.4M
Total Liabilities Q2 2020 · Dec 31, 2019 $16.84M
Current Assets Q2 2020 · Jun 30, 2020 $110.42M
Current Assets Q2 2020 · Dec 31, 2019 $19.97M
Total Assets Q2 2020 · Jun 30, 2020 $113.51M
Total Assets Q2 2020 · Dec 31, 2019 $21.02M
Sga Expense Q2 2020 · Jun 30, 2020 $2.3M
Sga Expense Q2 2020 · Jun 30, 2020 $3.86M
Sga Expense Q2 2020 · Jun 30, 2019 $840K
Sga Expense Q2 2020 · Jun 30, 2019 $1.61M
Rd Expense Q2 2020 · Jun 30, 2020 $8.86M
Rd Expense Q2 2020 · Jun 30, 2020 $15.8M
Rd Expense Q2 2020 · Jun 30, 2019 $4.93M
Rd Expense Q2 2020 · Jun 30, 2019 $10.02M
Net Income Q2 2020 · Jun 30, 2020 −$9.24M
Net Income Q2 2020 · Jun 30, 2020 −$15.66M
Net Income Q2 2020 · Jun 30, 2019 −$5.69M
Net Income Q2 2020 · Jun 30, 2019 −$11.49M
Operating Income Q2 2020 · Jun 30, 2020 −$9.2M
Operating Income Q2 2020 · Jun 30, 2020 −$15.71M
Operating Income Q2 2020 · Jun 30, 2019 −$5.77M
Operating Income Q2 2020 · Jun 30, 2019 −$11.63M
Revenue Q2 2020 · Jun 30, 2020 $1.96M
Revenue Q2 2020 · Jun 30, 2020 $3.96M